Introduction
is uncommon in the young, unlike in the elderly. An age >50 years had been 1 minor criterion for a presumptive diagnosis of IPF/UIP based on the 2000 American Thoracic Society (ATS)-European Respiratory Society (ERS) consensus statement [5] , although this minor criterion has now been removed. However, there have been few large studies of HRCT findings, HRCT diagnosis, and clinical diagnosis of chronic IP with a poor prognosis in the young. In this study, we retrospectively evaluated HRCT findings and clinical diagnoses of chronic IP with a poor prognosis in the young ≤50 years.
Materials and methods
Informed consent was obtained from all patients before performing computed tomography (CT). The ethics committee at our institution approved the present retrospective study and waived the requirement for informed consent for the use of medical patient data.
Patients
Between October 1998 and December 2010, 115 patients with severe lung disease were enrolled in the Japan Organ Transplant Network at our institution. Of these, 17 patients with IP fulfilled all of the following criteria of this study: ≤50 years, a treatment period ≥1 year, underwent HRCT, and underwent pathologic diagnosis of the whole lung. Two patients were excluded because of unavailable HRCT imaging or iatrogenic IP caused by bone marrow transplantation. Thus, 15 patients [8 men and 7 women; mean age 34.8 years ± 10.8 (standard deviation); range 13-50 years] were included in this study (Table 1) . Thirteen patients underwent bilateral lung transplantation and 1 underwent single lung transplantation; 1 died of progression of lung disease and underwent autopsy. Four patients had a history of connective tissue disease (CTD), 2 had a familial history of IPF/UIP, and 3 had both. Eight patients did not meet the criteria of lung-dominant CTD [6] , and these 8 patients had neither the clinical nor serologic features indicative of IP with autoimmune features, based on the classification criteria [7] . No significant occupational exposure was reported in any patient. Four patients had a smoking history (mean 30.6 pack-years; range 13-62.5 pack-years) and the others had never smoked. All patients were resistant to medical therapy and exhibited respiratory depression. They fulfilled 1 of the following conditions: vital capacity or total lung capacity under 60 % of the predictive value, hypoxemia at rest under 60 Torr, or grade III to V dyspnea according to the Hugh-Jones classification [8] .
Evaluation of HRCT findings
All patients underwent CT (Aquilion 16 or Aquilion 64; Toshiba Medical Systems Corporation, Otawara, Japan; or Light Speed Scanner; GE Healthcare, Milwaukee WI, USA) within 5 months of undergoing lung transplantation or at autopsy. CT images were obtained at the end of inspiration with patients in the supine position. The HRCT scanning protocol consisted of the reconstruction of 1-to 3-mm collimation sections with a high spatial frequency algorithm at 1-or 2-cm intervals. CT images were photographed at window settings appropriate for viewing the lung parenchyma (window level −600 to −700 Hounsfield Units; window width, 1200-1500 Hounsfield Units). HRCT images were reviewed retrospectively by consensus by 3 thoracic radiologists with 8, 22, and 33 years of experience, respectively. Observers were blinded to the clinical and histological information. Consensus interpretation was simultaneously arrived at by the 3 radiologists by discussion. The presence of the following 10 abnormal HRCT findings were evaluated: intralobular reticular opacity, air cysts (including emphysematous bulla), honeycombing, ground glass opacity (GGO), air space consolidation, traction bronchiectasis, interlobular septal thickening, thickening of the bronchovascular bundle, distortion, and ill-defined centrilobular nodules. These abnormal HRCT findings were defined based on previous definitions [9, 10] . If intralobular reticular opacity overlapped with GGO, intralobular reticular opacity was given priority. If GGO appeared without reticular opacity, the abnormal finding was evaluated as GGO.
The lungs were divided into 6 zones (the upper, middle, and lower zones in both lungs). The upper zone was defined as the lung above the level of the tracheal carina; the lower zone as the lung below the level of the inferior pulmonary vein; and the middle zone as the lung portion between the upper and lower zones. The extent of involvement of abnormal HRCT findings was evaluated visually and independently in each lung zone. For 5 findings (intralobular reticular opacity, air cysts, honeycombing, GGO, and air space consolidation), a score was assigned on the basis of the percentage of lung parenchyma that showed evidence of abnormal findings and was estimated to the nearest 5 % of parenchymal involvement based on the scoring system reported by Sumikawa et al. [11] . The overall percentage of involvement (i.e., median and mean scores of the 6 lung zones) was calculated.
After assessing the presence and extent of abnormal findings, observers evaluated the predominant distribution of the findings. Predominance was assessed as being in the "upper lung zone," "lower lung zone," or as "diffuse lung involvement." Upper lung zone predominance was considered present when most abnormal findings were above the level of the tracheal carina; lower zone predominance was considered present when most abnormal findings were below this level; and diffuse lung involvement was considered present when neither was predominant.
The anatomic distribution was also evaluated and noted to be a "peripheral pattern" if there was a predominance of abnormal findings in the outer third of the lung, a "peribronchovascular pattern" if there was predilection for the peribronchovascular areas, or a "diffuse pattern" if there was no predominance. Observers finally classified the cases as a "UIP pattern," "possible UIP pattern," or "inconsistent with UIP pattern," according to the 2010 ATS-ERS consensus statement [1] . In addition, HRCT findings were diagnosed as "indeterminate UIP pattern," according to the categories reported by Chung et al. [12] , when the findings were not suitable for any of these 3 patterns.
Pathologic and clinical diagnosis
All whole lung specimens were reviewed by a lung pathologist with 34 years of experience. All pathologic specimens were fixed with 10 % formalin, embedded in paraffin wax, and stained with hematoxylin-eosin or elastica-Masson stain for conventional microscopy. Pathologic images were obtained through a digital microscope camera (DS-Fi1; Nikon; Tokyo, Japan). All patients were classified into subgroups according to the 2010 ATS-ERS consensus statement [1] . Thereafter, all patients were clinically diagnosed according to the consensus statement [1] . Patients were diagnosed with "unclassified IP" when both the multidisciplinary diagnosis did not satisfy the criteria for a UIP pattern and the histologic patterns were not classified as any other type of IP.
Statistical analysis
Friedman's test and Wilcoxon's signed-rank test with Bonferroni correction were used to compare the extent of 5 abnormal findings (intralobular reticular opacity, air cysts, honeycombing, GGO, and air space consolidation). Thereafter, we compared the most extensive finding with the other 4 findings. P values <0.05 for Friedman's test and <0.0125 for Wilcoxon's signed-rank test with Bonferroni correction were considered statistically significant. All statistical analyses were performed using SPSS software (version 22.0; IBM, Armonk, NY, USA).
Results
A summary of each patient is shown in Table 1 .
HRCT findings and diagnosis
The mean total extent of parenchymal abnormalities on HRCT was 85 % ± 17. Intralobular reticular opacity, air cysts, GGO, traction bronchiectasis, and interlobular septal thickening were present in all patients. HRCT findings are shown in Table 2 . The most extensive finding was intralobular reticular opacity (median 37.5 %; mean 39 %; interquartile range 15-65 %). The median extent of air cysts, honeycombing, GGO, and air space consolidation was 10 % (mean 19 %; interquartile range 5-20 %), 5 % (mean 10 %; interquartile range 0-10 %), 5 % (mean 9 %; interquartile range 5-10 %), and 5 % (mean 7 %; interquartile range 5-10 %), respectively ( Table 2 ). The median maximum size of honeycombing on the HRCT images of the patients was 2.9 mm (mean 3.5 mm; interquartile range 1.7-6.0 mm). Only 1 patient (patient 13) had honeycombing >10 mm.
In multiple comparisons, there were significant differences (P = 0.01) by Friedman's test. Intralobular reticular opacity was significantly higher than 3 other findings [vs GGO (P = 0.003), consolidation (P = 0.001), and honeycombing (P = 0.009); Wilcoxon's signed-rank test with Bonferroni correction].
Regarding distributions on HRCT images, lower lung predominance, upper lung predominance, and diffuse lung involvement were present in 6, 3, and 6 patients, respectively (Table 3 ). The anatomic distributions were noted to be a peripheral pattern, peribronchovascular pattern, and diffuse pattern in 3, 5, and 7 patients, respectively ( Table 3) . The diagnoses from HRCT findings were UIP pattern (n = 2; Fig. 1 ), inconsistent with UIP pattern (n = 11; Fig. 2) , and indeterminate UIP pattern (n = 2) ( Table 1) . In 2 patients, HRCT findings were diagnosed as "indeterminate UIP pattern" because the images showed uniformly diffuse abnormal findings in the whole lung (Fig. 3) .
Pathologic and clinical diagnosis
The pathologic diagnoses were "UIP" (n = 5), "probable UIP" (n = 4), "possible UIP" (n = 1) and "not UIP" (n = 5). Microscopic honeycombing was seen in 13 cases (87 %). However, most honeycombing was very small (<2 mm) and included mucus retention. None of patients, except for those diagnosed as having IP with CTD, had pathological features indicative of IP with autoimmune disease. Intralobular reticular opacities on the HRCT images corresponded to marked fibrosis such as bridging fibrosis in the pathologic findings.
Multidisciplinary diagnoses were IPF/UIP (n = 1), possible IPF/UIP (n = 1), IP with CTD [UIP (n = 2), fibrotic nonspecific interstitial pneumonia (NSIP; n = 2), unclassified (n = 3)], fibrotic NSIP (n = 1), and unclassified IP (n = 5).
One patient, whose HRCT diagnosis was "indeterminate UIP pattern" and pathological diagnosis was "probable UIP," was diagnosed as having unclassified IP. In 4 of 8 patients who did not meet the criteria of CTD, pathological findings revealed marked centrilobular fibrosis and bridging fibrosis, which are common in chronic hypersensitivity Total (%) 3 (20) 5 (33) 7 (47) 15 (100) pneumonitis (CHP). However, because they had neither the other pathologic features nor clinical features of CHP, their pathologic diagnosis was "not UIP" and the multidisciplinary diagnosis was "unclassified IP."
Discussion
Several diseases, such as IPF/UIP, familial IPF, and CTD-related IP were reported as chronic IP in the young <50 years [4] . IPF/UIP was uncommon in our 15 younger patients; only 2 patients (13 %) were clinically diagnosed with IPF/UIP. Many investigators have already reported detailed HRCT findings of IPF/UIP [11] [12] [13] [14] [15] [16] . Honeycombing is a core finding of IPF/UIP and is helpful when distinguishing this disease from other IPs [11] . Abnormal findings exist predominantly in the peripheral and lower lung zones [11, 13, 17] . Additionally, GGO and reticular opacity were reported as other predominant findings [17] . The majority of our HRCT findings were different from typical findings of IPF/UIP. Our results showed an extremely large disease extent (mean 85 %) in the whole lung compared with previous reports (34.1 % [11] and 20.17-28.60 % [18] ). In addition, intralobular reticular opacity was the most extensive finding (median and mean scores 37.5 and 39 %, respectively). Conversely, the honeycombing score (median and mean 5 and 10 %, respectively) was not so different in extent in the whole lung, in contrast with previous reports (mean score, 4.4 % [11] and 7.04 % [18] ). Furthermore, distributions were different from those of typical IPF/UIP: abnormal findings existed predominantly in both the peripheral and lower lung zones in only 1 patient (7 %).
The wider extent of abnormal findings on HRCT images in the present study seemed to be consistent with the findings of end-stage IP. Honeycombing was said to enlarge slowly over time [14, 19] . However, honeycombing on the HRCT images was smaller in our study than The peripheral area of dense fibrosis contains bronchiectatic spaces (arrows). The internal lung tissue is divided by fibrosis connecting bronchioles or interlobular septa, which appears as "bridging fibrosis" (arrowheads). Normal lung tissue remains in fibrous connection. The patient's pathological diagnosis is "not UIP" in previous reports [19] . Honeycombing was observed pathologically in all patients, except 2 patients, although most honeycombing was smaller than 2 mm and included mucus retention. Therefore, honeycombing could not been detected on HRCT. Although 10 patients were pathologically diagnosed with UIP, probable UIP, or possible UIP, only 2 were diagnosed with UIP pattern based on HRCT images. We presumed that another reason for the discrepancy between the HRCT and pathologic findings was as follows: the craniocaudal distributions were different from those of typical IPF/UIP. Upper or mid-lung predominance is 1 HRCT criterion for "inconsistent with UIP pattern" [1] ; upper lung predominance was seen in 3 patients (20 %).
Our results showed that reticular opacity was the most common finding on HRCT imaging, although it was unclear whether this finding existed from an early stage because the patients' progress was not followed from an early stage. If reticular opacity exists in the majority of patients with early-stage IP with a poor prognosis but does not exist in patients with IP with a better prognosis, this finding may be a predictor of poor convalescence in younger patients with IP with a poor prognosis.
Familial IPF is a rare condition defined as the presence of IPF in at least 2 family members [5] and is a distinct entity that should be considered separately from non-familial IPF [20] . In our study, 2 patients (13 %) had familial IPF without CTD. Familial IPF accounts for less than 5 % of all patients with IPF [21] [22] [23] . Nadrous et al. [4] reported that 3 (14 %) of 22 IPF/UIP patients <50 years had familial histories. Nishiyama et al. [24] reported that the HRCT findings of familial IPF resemble those of sporadic IPF; however, familial IPF had a lower prevalence of honeycombing and a lower prevalence of a lower lung predominant distribution than nonfamilial IPF. In one of our 2 patients, had atypical UIP pattern on HRCT; the abnormalities showed diffuse lung involvement.
Patients with CTD-related UIP were younger than patients with IPF/UIP [18, 25] . Patients may subsequently manifest overt features of an underlying CTD that was subclinical at the time IP was diagnosed [25] . Patients with CTD-related IP have a better prognosis than patients with idiopathic IP [26, 27] . However, IP is referred to as 1 factor related to a poor CTD prognosis [28] . The present study included 7 patients (47 %) with a history of CTD. No patient except 1 was diagnosed with UIP pattern based on HRCT findings, while 5 of 7 were diagnosed as having UIP/probable UIP based on pathologic findings. This discrepancy may be because honeycombing was hidden in reticular shadows on HRCT images. Kono et al. [25] reported that HRCT imaging showed no statistically significant difference between the CTD-related UIP and IPF/UIP groups with regard to the presence or distribution of each finding. Conversely, Song et al. [18] reported that patients with CTD-related IP often had atypical IPF/UIP patterns and had marginally significantly lower scores for honeycombing compared with IPF/UIP patients; their results were similar to ours.
This retrospective study enrolled a small number of patients, and there was the potential for a patient selection bias, as all patients were from a single institution. toxylin-eosin stained sample shows honeycombing (arrows) in the peripheral zone (left side of the image) and inflammatory and fibrous changes (arrowheads) without honeycombing in the internal zone (right side of the image), and is diagnosed as "probable UIP (atypical)." The borders of the 2 zones are unclear. The size of honeycombing is very small, as seen in idiopathic pulmonary fibrosis Only a small proportion of younger patients with chronic IP with a poor prognosis were evaluated. Three radiologists simultaneously performed a consensus interpretation of evaluation of HRCT findings. The results may have been affected by the senior radiologist's interpretation. It is very difficult to diagnose CHP histologically [29] . Four patients had the pathological findings of centrilobular fibrosis and bridging fibrosis; however, the multidisciplinary diagnosis was unclassified IP. Therefore, patients with CHP may have actually been included. Our study was not designed to compare the clinical, radiological, and pathological features of the young with IP with a poor prognosis with those with a better prognosis. Additionally, only patients whose whole lung was obtained by transplantation or autopsy were enrolled. Thus, our study enrollment decreased. However, this study is interesting and important because there has been no previous report evaluating radiological, pathological, and clinical diagnoses using the whole lung in the young with chronic IP with a poor prognosis. The specimen obtained by surgical biopsy was an evaluation of only a part of the organ, and the condition of the lung at autopsy is worse because of post mortem changes.
In conclusion, the most extensive HRCT finding was intralobular reticular opacity. Most HRCT images differed from typical IPF/UIP. IPF/UIP was uncommon in the young with chronic IP with a poor prognosis.
